查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585638

生物安全柜市场：按类型、最终用户划分 - 2025-2030 年全球预测

Biological Safety Cabinet Market by Type (Class I, Class II, Class III), End User (Academic & Research Organizations, Diagnostics & Testing Laboratories, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物安全柜市场价值为4.5646亿美元，预计2024年将达到4.9474亿美元，复合年增长率为8.47%，到2030年将达到8.0693亿美元。

研究实验室 (BSC) 是一个封闭、通风的实验室工作空间，旨在保护居住者和环境免受病原微生物的侵害，用于生物医学、製药和生物技术研究应用。平衡计分卡在确保实验室、工业环境和医疗机构的生物安全和防止污染方面发挥重要作用，凸显了对平衡计分卡的需求。应用和最终用途范围广泛，从研究机构和临床实验室到医院和製药公司，在 COVID-19 等全球健康威胁中，由于对严格安全标准的需求，其采用率不断增加。影响 BSC 市场的关键成长要素包括感染疾病的增加、生物安全问题的增加以及有关实验室工作人员安全的严格法规结构。改进的气流系统和先进的过滤技术等技术进步，以及对研发和医疗基础设施的投资增加，特别是在新兴市场，提供了潜在的成长机会。然而，市场成长面临初始成本高、维护要求复杂以及监管核准流程冗长等挑战，可能会阻碍小型实验室采用平衡计分卡。为了利用新的商机，企业可以专注于创新领域，例如开发节能模型、整合数位监控系统以及在设计和製造中探索环保材料。我们还可以透过促进与研究机构的伙伴关係和合作来推动创新解决方案。市场竞争温和，主要参与企业不断创新以维持其市场地位并遵守不断变化的安全标准。希望发展业务的公司应该投资强大的研发策略，开拓新兴市场，并提供客製化服务以满足特定实验室的要求。这种研究驱动的创新方法将有助于克服现有的市场挑战，并有效满足对生物安全柜不断增长的需求。

主要市场统计
基准年[2023] 4.5646亿美元
预测年份 [2024] 4.9474 亿美元
预测年份 [2030] 80693万美元
复合年增长率（%） 8.47%

市场动态：揭示快速发展的生物安全柜市场的关键市场洞察

供需的动态交互作用正在改变生物安全柜市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 利好法规促进生物安全柜在医疗产业的使用
    • 流行病和传染病的风险增加
    • 生技药品数量快速增加
  • 市场限制因素
    • 替代存储
  • 市场机会
    • 生物製药和製药公司的研发活动增加
    • 生技药品数量快速增加 发展中国家医疗基础建设投资增加
  • 市场问题
    • 开发低成本、高品质的生物安全柜

波特的五力：驾驭生物安全柜市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物安全柜市场的外部影响

外部宏观环境因素在塑造生物安全柜市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解生物安全柜市场的竞争格局

生物安全柜市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵生物安全柜市场供应商的绩效评估

FPNV定位矩阵是评估生物安全柜市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製生物安全柜市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物安全柜市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 利好法规促进生物安全柜在医疗产业的使用
      • 流行病和传染病的风险增加
      • 生技药品快速成长
    • 抑制因素
      • 替代储物柜
    • 机会
      • 生物製药和製药公司的研发活动增加
      • 生技药品的快速成长增加了成长中经济体对卫生基础设施的投资
    • 任务
      • 开发低成本、高品质的生物安全柜
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物安全柜市场：依类型

  • 介绍
  • Ⅰ类
  • 二级
    • Ⅱ类A型
    • II 类 B 型
  • 三级

第七章生物安全柜市场：依最终用户分类

  • 介绍
  • 学术/研究机构
  • 诊断和测试实验室
  • 製药和生物製药公司

第八章美洲生物安全柜市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物安全柜市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲生物安全柜市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Air Science USA LLC by PyroGenesis Canada Inc.
  • Alpha Linear
  • Berner International GmbH
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone SpA
  • Flow Sciences, Inc.
  • Germfree Laboratories, Inc.
  • Haier Biomedical
  • Kewaunee Scientific Corporation
  • Labconco Corporation
  • Stericox India Private Limited
  • The Baker Company
  • Thermo Fisher Scientific Inc.
  • TopAir Systems Inc.
Product Code: MRR-437D4595793A

The Biological Safety Cabinet Market was valued at USD 456.46 million in 2023, expected to reach USD 494.74 million in 2024, and is projected to grow at a CAGR of 8.47%, to USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is an enclosed, ventilated lab workspace designed to protect both the user and the environment from pathogenic microorganisms, with applications spanning biomedical, pharmaceutical, and biotechnological research. The necessity of BSCs is underscored by their critical role in ensuring biosafety and preventing contamination in laboratories, industrial settings, and healthcare facilities. The application and end-use scope are vast, extending from research institutions and clinical laboratories to hospitals and pharmaceutical companies, with increasing adoption driven by the need for stringent safety standards amid global health threats like COVID-19. Significant growth factors influencing the BSC market include the rise of infectious diseases, escalating biosecurity concerns, and stringent regulatory frameworks regarding laboratory personnel safety. Technological advancements, such as improved airflow systems and advanced filtration technologies, offer potential growth opportunities, along with increased investment in R&D and healthcare infrastructure, particularly in emerging markets. However, market growth faces challenges such as high initial costs, complex maintenance requirements, and a lengthy approval process from regulatory bodies, which may deter small-scale labs from adopting BSCs. To capitalize on emerging opportunities, companies can focus on areas of innovation, such as developing energy-efficient models, integrating digital monitoring systems, and exploring eco-friendly materials in design and manufacturing. Encouraging partnerships and collaborations with research institutions can also drive forward innovative solutions. The market presents a moderately competitive landscape with key players consistently innovating to maintain market presence and comply with evolving safety standards. Enterprises aiming for business growth should invest in robust R&D strategies, tap into emerging markets, and offer customization to meet specific lab requirements. This research-centered innovation approach could help in overcoming the existing market challenges and cater to the growing biosafety cabinet demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 456.46 million
Estimated Year [2024] USD 494.74 million
Forecast Year [2030] USD 806.93 million
CAGR (%) 8.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Cabinet Market

The Biological Safety Cabinet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • Increased risk of pandemics and communicable diseases
    • Rapid growth in the number of biologics
  • Market Restraints
    • Alternative containment cabinet
  • Market Opportunities
    • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • Market Challenges
    • Development of low cost high quality biological safety cabinets

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Cabinet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Cabinet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Cabinet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Cabinet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Cabinet Market

A detailed market share analysis in the Biological Safety Cabinet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Cabinet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Cabinet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Cabinet Market

A strategic analysis of the Biological Safety Cabinet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Class I, Class II, and Class III. The Class II is further studied across Class II Type A and Class II Type B.
  • Based on End User, market is studied across Academic & Research Organizations, Diagnostics & Testing Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
      • 5.1.1.2. Increased risk of pandemics and communicable diseases
      • 5.1.1.3. Rapid growth in the number of biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Alternative containment cabinet
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
      • 5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Development of low cost high quality biological safety cabinets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Safety Cabinet Market, by Type

  • 6.1. Introduction
  • 6.2. Class I
  • 6.3. Class II
    • 6.3.1. Class II Type A
    • 6.3.2. Class II Type B
  • 6.4. Class III

7. Biological Safety Cabinet Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Organizations
  • 7.3. Diagnostics & Testing Laboratories
  • 7.4. Pharmaceutical & Biopharmaceutical Companies

8. Americas Biological Safety Cabinet Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biological Safety Cabinet Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biological Safety Cabinet Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Science USA LLC by PyroGenesis Canada Inc.
  • 2. Alpha Linear
  • 3. Berner International GmbH
  • 4. Biobase Biodusty (Shandong), Co., Ltd.
  • 5. Esco Micro Pte. Ltd.
  • 6. EuroClone S.p.A.
  • 7. Flow Sciences, Inc.
  • 8. Germfree Laboratories, Inc.
  • 9. Haier Biomedical
  • 10. Kewaunee Scientific Corporation
  • 11. Labconco Corporation
  • 12. Stericox India Private Limited
  • 13. The Baker Company
  • 14. Thermo Fisher Scientific Inc.
  • 15. TopAir Systems Inc.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAFETY CABINET MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS & TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023